Top 10 life sciences projects: Uppsala Business Park, Uppsala, Sweden

Project overview

Uppsala Business Park (UBP) is one of northern Europe’s leading life-sciences hubs, integrating biopharma, medtech, diagnostics and advanced manufacturing within the Uppsala-Stockholm region, home to more than 30,000 life science professionals.

The park hosts over 60 companies and 4,000 employees, ranging from startups to global leaders, including Thermo Fisher, Johnson & Johnson, Fresenius Kabi and Cytiva. Spanning 25 hectares and owned by Corem Property Group, the site includes 3,000 sq m of leasable space and 150,000 sq m of building rights.

Located south of Uppsala with direct access to the E4 corridor and Arlanda International Airport,
it benefits from strong regional connectivity, research intensity and global market access.

The opportunity

A flexible structural plan supports laboratories, research, office, industrial and production uses within a sustainably designed framework. The 150,000 sq m of undeveloped land offers scope for acquisition and new development, while existing, adaptable facilities provide immediate leasing opportunities, including lab space.

The park is positioned to attract operators seeking expansion within a mature life sciences ecosystem, supported by strong transport links, access to skilled labour and proximity to world-class universities and research institutes.

Financials

UBP offers a range of potential short-, medium- and long-term investment opportunities. The structural plan offers more than SEK5 billion for investors, co-development, constructors and equity.

Lease agreements offer tenants access to high-spec premises at competitive rates and options are available for acquisition and development.

Project sponsor

Uppsala Business Park is developed by Corem Property Group, a major commercial real estate company based in Sweden, which holds a portfolio of commercial premises totalling 2.1 million sq m, primarily within Sweden.

Significance

The site is both significant and historic within the life sciences segment. For the city and the region, UBP provides competitive capacity and jobs, and contributes to what is Sweden’s primary growth zone for research and
life sciences.

For the industry, it provides innovation through its community and collaboration.

Pitch

UBP offers a rare combination of scale, talent and connectivity within one of Europe’s strongest life sciences regions, with leading global companies already established on site – making it a strategically attractive destination for direct investment, development and long-term value creation.